Genex Pharmaceutical, Inc.
GENXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1788
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Genex Pharmaceutical, Inc. (GENX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GENX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2007-12 | 2006-12 | 2005-12 | 2004-12 | 2003-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.24M | $2.44M | $2.49M | $2.35M | $0.00M |
| Cost of Revenue | $0.36M | $0.22M | $0.30M | $0.28M | $0.00M |
| Gross Profit | $2.87M | $2.22M | $2.19M | $2.07M | ($0.00M) |
| Gross Margin %(computed) | 88.80% | 91.08% | 87.87% | 87.97% | -8.64% |
| Operating Expenses | |||||
| R&D Expenses | $0.20M | $0.00M | $0.09M | $0.00M | $0.00M |
| G&A Expenses | $1.18M | $0.70M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $2.41M | $1.37M | $1.27M | $1.08M | ($0.05M) |
| Operating Income | $0.47M | $0.85M | $0.92M | $0.99M | $0.05M |
| Operating Margin %(computed) | 14.40% | 34.73% | 36.95% | 42.22% | — |
| Interest Income | $0.25M | $0.18M | $0.07M | $0.02M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $0.73M | $1.03M | $0.95M | $1.01M | $0.00M |
| Income Tax Expense | $0.39M | $0.41M | $0.33M | $0.00M | $0.00M |
| Net Income | $0.34M | $0.62M | $0.63M | $1.01M | ($0.05M) |
| Net Margin %(computed) | 10.58% | 25.39% | 25.09% | 43.12% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.02 | $0.03 | $0.04 | $0.06 | $-0.01 |
| Wtd Avg Shares | 17.85M | 17.85M | 17.85M | 17.85M | 11.36M |
| EBITDA | $0.79M | $0.90M | $0.98M | $1.05M | ($0.05M) |
| EBITDA Margin %(computed) | 24.40% | 37.02% | 39.36% | 44.71% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Genex Pharmaceutical, Inc. data
About Genex Pharmaceutical, Inc. (GENX) Income Statement
Genex Pharmaceutical, Inc. (GENX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2007, GENX reported revenue of $0.00B, gross profit of $0.00B (gross margin 88.80%), and net income of $0.00B — a net profit margin of 10.58%.
Frequently asked questions
GENX · 4 questionsGenex Pharmaceutical, Inc. (GENX) reported revenue of $0.00B for 2007, up 32.8% year-over-year.
GENX revenueGENX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09